INTRABEAM: precision hypo-fractionated radiotherapy with a systemic immune response

Linares, I ; Berenguer, M.A ; Martínez, E ; Laplana, M ; Cañas, R ; Comas, S ; Pérez Montero, H ; Ventura, M ; Guedea, F

Elsevier BV 2019

Texto completo disponível

Acute hepatic porphyria disease manifestations and daily life impacts in EXPLORE international, prospective, natural history study

Gouya, L ; Balwani, M ; Bissell, DM ; Rees, D ; Stolzel, U ; Phillips, J ; Kauppinen, R ; Langendonk, J ; Desnick, R ; Deybach, JC ; Bonkovsky, H ; Parker, C ; Naik, H ; Badminton, M ; Stein, P ; Minder, E ; Windyga, J ; Martasek, P ; Cappellini, MD ; Ventura, P ; Sardh, E ; Harper, P ; Sandberg, S ; Aarsand, A ; Alegre, F ; Ivanova, A ; Talbi, N ; Ko, J ; Cahana-Amitay, D ; Chan, A ; Dinh, Q ; Penz, C ; Simon, A ; Lin, T ; Anderson, K

Texto completo disponível

Management of acute hepatic porphyria attacks in europe and united states: EXPLORE international, prospective, natural history study

Sardh, E ; Balwani, M ; Gouya, L ; Bissell, DM ; Rees, D ; Stolzel, U ; Phillips, J ; Kauppinen, R ; Langendonk, J ; Desnick, R ; Deybach, JC ; Bonkovsky, H ; Parker, C ; Naik, H ; Badminton, M ; Stein, P ; Minder, E ; Windyga, J ; Martasek, P ; Cappellini, MD ; Ventura, P ; Harper, P ; Sandberg, S ; Aarsand, A ; Alegre, F ; Ivanova, A ; Talbi, N ; Ko, J ; Cahana-Amitay, D ; Chan, A ; Dinh, Q ; Penz, C ; Simon, A ; Lin, T ; Anderson, K

Texto completo disponível

Early experience and quality of life in SBRT prostate cancer boost of 9 Gy in a phase II trial

Ferrer, Ferran ; Pont, Àngels ; Blas, Rodolfo de ; Boladeras, Anna ; Garin, O ; Ventura, Montse ; Zardoya, Eva ; Delgado, J ; Condom, E ; Merino, E ; Mases, Joel ; Castells-Esteve, Manel ; Guix, Inés ; Suarez, Jose Francisco ; Gonzalez, Javier ; Almendros, Sonia ; Garcia, M ; Berenguer, Miguel Ángel ; Garcia, N ; Stefanovic, M ; Gutierrez, Cristina ; Picon, Cristina ; Ferrer, Montserrat ; Guedea Edo, Ferran

Elsevier BV 2019

Texto completo disponível

ENVISION, a phase 3 study to evaluate efficacy and safety of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1, in acute hepatic porphyria patients

Balwani, M ; Gouya, L ; Rees, D ; Stein, P ; Stolzel, U ; Aguilera, P ; Bissell, DM ; Bonkovsky, H ; Keel, S ; Parker, C ; Phillips, J ; Silver, S ; Windyga, J ; D'avola, D ; Ross, G ; Stewart, P ; Ritchie, B ; Oh, J ; Harper, P ; Wang, JD ; Langendonk, J ; Ivanova, A ; Horie, Y ; Anderson, K ; Ventura, P ; Chan, A ; Penz, C ; Simon, A ; Dinh, Q ; Liu, G ; Sardh, E

Texto completo disponível

End-stage renal disease in familial amyloidosis ATTR VaI30Met: A definitive indication to combined liver-kidney transplantation

LOBATO, L ; VENTURA, A ; BEIRAO, I ; MIRANDA, H. P ; SECA, R ; HENRIQUES, A. C ; TEIXEIRA, M ; SARMENTO, A. M ; PEREIRA, M. C

New York, NY: Elsevier Science

Texto completo disponível

Diabetes and memory

ZUCCARO, S. M ; MENASCI, A ; CALVETTI, D ; VENTURA, C ; PAPARELLA, D ; PALLESCHI, L ; COEN, D ; SPIZZICHINO, S ; MANOR, M

Shannon: Elsevier

Texto completo disponível

Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation. Discussion

MANORD, J. D ; GARRARD, C. L ; SMITH, R. B ; BLACKSHEAR, W. M ; MEHRA, M. R ; STERNBERGH, W. C ; BALLINGER, B ; VENTURA, H. O ; STAPLETON, D. D ; SMART, F. W ; BOWEN, J. C ; MONEY, S. R

New York, NY: Elsevier

Texto completo disponível